Digital Therapeutics Market to Observe Prominent Growth of USD 20.0 billion with Excellent CAGR of 21.54% Size, Share, Trends, Industry Growth Rate, Demand & Forecast by 2029
The comprehensive Digital Therapeutics Market report endows with statistics on the current state of the industry and hence works as a valuable source of guidance and direction for companies and investors interested in this market. To have finest market insights and knowhow of the most excellent market opportunities into the specific markets, this market research report is an ideal option. The report proves to be a thorough synopsis on the study, analysis and estimation of the market and how it is affecting the Healthcare industry. Besides, Digital Therapeutics market report comprises of an extensive evaluation of the market’s growth prospects and restrictions.
Data
Bridge Market Research analyses a growth rate in the global digital
therapeutics market in the forecast period 2022-2029.
The expected CAGR of global digital therapeutics market is tend to be around
21.54% in the mentioned forecast period. The market was valued at USD 4.20
billion in 2021, and it would grow upto USD 20.0 billion by 2029.
Request
Sample of Digital Therapeutics Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digital-therapeutics-market
A
list of all the renowned Digital Therapeutics Key Players in the market:
v Omada Health, Inc.
(U.S.)
v ResMed (U.S.)
v Pear Therapeutics,
Inc. (U.S.)
v Solera Network
(U.S.)
v Akili Interactive
Labs, Inc. (U.S.)
v Better Therapeutics,
LLC (U.S.)
v Biofourmis (U.S.)
v Click Therapeutics,
Inc. (U.S.)
v Naturalcycles Nordic
AB (Sweden)
v NuvoAir AB (Sweden)
v Welldoc’s Bluestar
(U.S.)
v Happify, Inc. (U.S.)
v Limbix Health, Inc.
(U.S.)
v Voluntis (U.S.)
v Xealth (U.S.)
Drivers
· Rising Chronic Diseases
The high incidence of chronic diseases along with
rising demand for controlled healthcare facilities and treatment costs has
boosted the demand for digital therapeutics. For instance, cardiovascular
disease (CVD) is leading to the death of 17.3 million people per year, and this
is expected to cross 23.6 million by 2022.
· Launch of new products
A strong line of potential products that are
expected to be launched during the forecast period also provide emerging
opportunities in the future. For instance, potential products of pear
therapeutics, clinical therapeutics products in phase III are Pear-011 (anxiety
GAD), Pear-015 (depression MDD) which are used in the treatment of chronic
insomnia and depression and CT-152 (major depressive disorder), CT-155
(schizophrenia) are used in the treatment of schizophrenia and depression.
Opportunities
· Emerging Market Growth
Emerging countries such as India, China, and the
Middle East present growth opportunities for digital therapeutics. Most
emerging countries show high rates of the incidence of chronic disease.
Developing countries like India and China lack government regulations for
digital health solutions, which provide potential to healthcare professionals
who cannot meet stringent standards set by FDA.
Key
Pointers in TOC of Digital Therapeutics Market Report:
Sections
1: Definition, Specifications and
Classification of Digital Therapeutics, Applications of Digital Therapeutics,
Market Segment by Regions
Sections
2: Technical Data and Manufacturing
Analysis of Digital Therapeutics, Capacity and R&D Status and Technology
Source, Raw Materials Sources Analysis
Sections
3: Market Analysis, Sales Examination,
sales Value Investigation
Sections
4: Regional Market Investigation that
incorporates North America, Europe, Asia Pacific, Latin America, Middle East
& Africa Market Examination
Sections
5: The Digital Therapeutics Segment
Market Analysis (by Application), Major Manufacturers Analysis of Digital
Therapeutics
Sections
6: Market Trend Analysis, Regional
Market Trend, Market Trend by Product Type
Sections
7: Regional Promoting Type
Investigation, Inventory network Investigation
Sections
8: The Customers Examination of global
Digital Therapeutics Market
Sections
9: Digital Therapeutics Research
Findings and Conclusion, Appendix, and information source
Sections
10: Digital Therapeutics deals channel,
wholesalers, merchants, traders, Exploration Discoveries and End, appendix and
data source.
Continued.....
Browse
in-depth TOC on “Digital Therapeutics Market”: By Type, Applications, Industry
Size, Share, Growth, Segments, Analysis and Forecast @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digital-therapeutics-market
Global Digital Therapeutics Market
Scope
The
global digital therapeutics market is segmented on the basis of product type,
sales channel and application. The growth amongst these segments will help you
analyze meagre growth segments in the industries and provide the users with a
valuable market overview and market insights to help them make strategic
decisions for identifying core market applications.
Product Type
·
Software
·
Devices
Sales Channel
·
B2C
·
B2B
Application
·
Preventive
Applications
·
Treatment/Care-related
Applications
Request
for PDF Brochure of This Report@ https://www.databridgemarketresearch.com/reports/global-digital-therapeutics-market
Have
a Look at Related Research Updates@
https://www.databridgemarketresearch.com/reports/europe-digital-therapeutics-market
https://www.databridgemarketresearch.com/reports/asia-pacific-digital-therapeutics-market
https://www.databridgemarketresearch.com/reports/middle-east-and-africa-digital-therapeutics-market
https://www.databridgemarketresearch.com/reports/north-america-digital-therapeutics-market
About Data Bridge Market
Research, Private Ltd
Data Bridge Market
Research Pvt Ltd is a
multinational management consulting firm with offices in India and Canada. As
an innovative and neoteric market analysis and advisory company with unmatched
durability level and advanced approaches. We are committed to uncover the best
consumer prospects and to foster useful knowledge for your company to succeed
in the market.
Contact:
Data
Bridge Market Research
US:
+1 888 387 2818
UK:
+44 208 089 1725
Hong
Kong: +852 8192 7475
Comments
Post a Comment